Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TreatmentX
AddedFeb 17, 2024
UpdatedJun 18, 2026
TreatmentX

TreatmentX

Seed

Treatment X: A data-driven startup revolutionizing cannabis research, funding, and patient care, based in Boulder, CO.

HQ
Boulder, CO, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded in Boulder, CO, TreatmentX is a pioneering data analytics startup dedicated to advancing cannabis research and funding solutions. The company's mission is to standardize Patient-Reported Outcomes (PROs) to enhance medical treatment plans, reduce production costs for manufacturers, and foster robust scientific research. TreatmentX serves as a crucial platform for doctors, researchers, and cannabis manufacturers, aiming to help patients use cannabis effectively as medicine through data-backed insights.

Notable affiliated individuals and investors have not been disclosed, but the company has made significant strides in the cannabis research sector. Key achievements include the development of standardized PROs that have improved patient care and treatment efficacy. TreatmentX's impact is evident in its role as a trusted resource for medical professionals and researchers, contributing to more effective and scientifically grounded cannabis treatments.

TreatmentX - Similar Companies

Patient Premier logo

Patient Premier

patientpremier.com

Cannformatics logo

Cannformatics

cannformatics.com

Trellis Research Group logo

Trellis Research Group

Cannabis Big Data logo

Cannabis Big Data

Treatment Technologies & Insights logo

Treatment Technologies & Insights

tti.care

Treatment Scores logo

Treatment Scores

KushStack logo

KushStack

dosist logo

dosist

dosist.com

Colorado Hemp Institute logo

Colorado Hemp Institute

HealClick logo

HealClick

healclick.com

Jointly logo

Jointly

jointlybetter.com

Gatc Canna logo

Gatc Canna

Trellis Health logo

Trellis Health

FindMeCure logo

FindMeCure

findmecure.com

Grassp Health logo

Grassp Health

TreatmentX - Quick Facts

Who are TreatmentX's competitors?

Companies similar to TreatmentX include Patient Premier, Cannformatics, Trellis Research Group and Cannabis Big Data.

When was TreatmentX founded?

TreatmentX was founded in 2018.

Where is TreatmentX's headquarters located?

TreatmentX's headquarters is located in Boulder, CO, US.

When was TreatmentX's last funding round?

TreatmentX's most recent funding round was for $30k (USD) in February 2018.

How much has TreatmentX raised to-date?

As of Feb 4, 2018, TreatmentX has raised a total of $30k (USD).

How many employees does TreatmentX have?

TreatmentX has 6 employees as of Feb 4, 2024.

TreatmentX - Classification

Ownership
  • Venture Capital
Technology
  • Data
Geographic Exposure
  • United States
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Analytics
  • Healthcare
Tags
  • Healthtech
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software